170 related articles for article (PubMed ID: 2857687)
1. Klebsiella pneumoniae: selected virulence factors that contribute to pathogenicity.
Highsmith AK; Jarvis WR
Infect Control; 1985 Feb; 6(2):75-7. PubMed ID: 2857687
[TBL] [Abstract][Full Text] [Related]
2. H-NS Nucleoid Protein Controls Virulence Features of Klebsiella pneumoniae by Regulating the Expression of Type 3 Pili and the Capsule Polysaccharide.
Ares MA; Fernández-Vázquez JL; Rosales-Reyes R; Jarillo-Quijada MD; von Bargen K; Torres J; González-y-Merchand JA; Alcántar-Curiel MD; De la Cruz MA
Front Cell Infect Microbiol; 2016; 6():13. PubMed ID: 26904512
[TBL] [Abstract][Full Text] [Related]
3. The Klebsiella pneumoniae YfgL (BamB) lipoprotein contributes to outer membrane protein biogenesis, type-1 fimbriae expression, anti-phagocytosis, and in vivo virulence.
Hsieh PF; Hsu CR; Chen CT; Lin TL; Wang JT
Virulence; 2016 Jul; 7(5):587-601. PubMed ID: 27029012
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of phagocytic-resistant capsular serotypes of Klebsiella pneumoniae in liver abscess.
Lin JC; Chang FY; Fung CP; Xu JZ; Cheng HP; Wang JJ; Huang LY; Siu LK
Microbes Infect; 2004 Nov; 6(13):1191-8. PubMed ID: 15488738
[TBL] [Abstract][Full Text] [Related]
5. CD36 Provides Host Protection Against Klebsiella pneumoniae Intrapulmonary Infection by Enhancing Lipopolysaccharide Responsiveness and Macrophage Phagocytosis.
Olonisakin TF; Li H; Xiong Z; Kochman EJ; Yu M; Qu Y; Hulver M; Kolls JK; St Croix C; Doi Y; Nguyen MH; Shanks RM; Mallampalli RK; Kagan VE; Ray A; Silverstein RL; Ray P; Lee JS
J Infect Dis; 2016 Dec; 214(12):1865-1875. PubMed ID: 27683817
[TBL] [Abstract][Full Text] [Related]
6. First two cases of severe multifocal infections caused by Klebsiella pneumoniae in Switzerland: characterization of an atypical non-K1/K2-serotype strain causing liver abscess and endocarditis.
Babouee Flury B; Donà V; Buetti N; Furrer H; Endimiani A
J Glob Antimicrob Resist; 2017 Sep; 10():165-170. PubMed ID: 28729207
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Diabetic and Non-diabetic Human Leukocytic Responses to Different Capsule Types of
Lee IR; Sng E; Lee KO; Molton JS; Chan M; Kalimuddin S; Izharuddin E; Lye DC; Archuleta S; Gan YH
Front Cell Infect Microbiol; 2017; 7():401. PubMed ID: 28936426
[TBL] [Abstract][Full Text] [Related]
8. Capsular Polysaccharide Types and Virulence-Related Traits of Epidemic KPC-Producing Klebsiella pneumoniae Isolates in a Chinese University Hospital.
Liu Y; Liu PP; Wang LH; Wei DD; Wan LG; Zhang W
Microb Drug Resist; 2017 Oct; 23(7):901-907. PubMed ID: 28437231
[TBL] [Abstract][Full Text] [Related]
9. [Investigation of various virulence factors of Klebsiella pneumoniae strains isolated from nosocomial infections].
Kuş H; Arslan U; Türk Dağı H; Fındık D
Mikrobiyol Bul; 2017 Oct; 51(4):329-339. PubMed ID: 29153063
[TBL] [Abstract][Full Text] [Related]
10. The role of capsular polysaccharide K21b of Klebsiella and of the structurally related colanic-acid polysaccharide of Escherichia coli in resistance to phagocytosis and serum killing.
Allen PM; Fisher D; Saunders JR; Hart CA
J Med Microbiol; 1987 Dec; 24(4):363-70. PubMed ID: 3320374
[TBL] [Abstract][Full Text] [Related]
11. Extracellular polysaccharide production by Klebsiella pneumoniae and its relationship to virulence.
Domenico P; Diedrich DL; Straus DC
Can J Microbiol; 1985 May; 31(5):472-8. PubMed ID: 3891056
[TBL] [Abstract][Full Text] [Related]
12. Application of flow cytometry to the study of antiphagocytic properties of Klebsiella pneumoniae capsular polysaccharide.
Ruiz C; Sabio JM; Santos JL; Montes MJ; Olivares EG
FEMS Immunol Med Microbiol; 1993 Jun; 7(1):63-6. PubMed ID: 8364523
[TBL] [Abstract][Full Text] [Related]
13. Evaluating Different Virulence Traits of
Marcoleta AE; Varas MA; Ortiz-Severín J; Vásquez L; Berríos-Pastén C; Sabag AV; Chávez FP; Allende ML; Santiviago CA; Monasterio O; Lagos R
Front Cell Infect Microbiol; 2018; 8():30. PubMed ID: 29479519
[TBL] [Abstract][Full Text] [Related]
14. Klebsiella pneumoniae: Going on the Offense with a Strong Defense.
Paczosa MK; Mecsas J
Microbiol Mol Biol Rev; 2016 Sep; 80(3):629-61. PubMed ID: 27307579
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of the contribution of the capsular polysaccharide and the lipopolysaccharide O side chain to the virulence of Klebsiella pneumoniae in a murine model of pneumonia.
Cortés G; Borrell N; de Astorza B; Gómez C; Sauleda J; Albertí S
Infect Immun; 2002 May; 70(5):2583-90. PubMed ID: 11953399
[TBL] [Abstract][Full Text] [Related]
16. Contribution of fucose-containing capsules in Klebsiella pneumoniae to bacterial virulence in mice.
Wu JH; Wu AM; Tsai CG; Chang XY; Tsai SF; Wu TS
Exp Biol Med (Maywood); 2008 Jan; 233(1):64-70. PubMed ID: 18156307
[TBL] [Abstract][Full Text] [Related]
17. Polysaccharide capsule-mediated resistance to opsonophagocytosis in Klebsiella pneumoniae.
Domenico P; Salo RJ; Cross AS; Cunha BA
Infect Immun; 1994 Oct; 62(10):4495-9. PubMed ID: 7927714
[TBL] [Abstract][Full Text] [Related]
18. Molecular pathogenesis of Klebsiella pneumoniae.
Li B; Zhao Y; Liu C; Chen Z; Zhou D
Future Microbiol; 2014; 9(9):1071-81. PubMed ID: 25340836
[TBL] [Abstract][Full Text] [Related]
19. Klebsiella pneumoniae triggers a cytotoxic effect on airway epithelial cells.
Cano V; Moranta D; Llobet-Brossa E; Bengoechea JA; Garmendia J
BMC Microbiol; 2009 Aug; 9():156. PubMed ID: 19650888
[TBL] [Abstract][Full Text] [Related]
20. Phagocyte-bacteria interactions.
Keisari Y; Kabha K; Nissimov L; Schlepper-Schafer J; Ofek I
Adv Dent Res; 1997 Apr; 11(1):43-9. PubMed ID: 9524441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
